Impact BioMedical Inc.
IBO
$0.4324
$0.00741.74%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 591.00K | 719.00K | 335.00K | 434.00K | 128.00K |
| Depreciation & Amortization | 279.00K | 281.00K | 279.00K | 280.00K | 280.00K |
| Other Operating Expenses | 113.00K | 45.00K | 12.00K | 7.00K | 101.00K |
| Total Operating Expenses | 875.00K | 1.13M | 626.00K | 771.00K | 1.14M |
| Operating Income | -875.00K | -1.13M | -626.00K | -771.00K | -1.14M |
| Income Before Tax | -27.10M | 4.24M | -884.00K | -998.00K | -1.26M |
| Income Tax Expenses | 33.00K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.13M | 4.24M | -884.00K | -998.00K | -1.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 25.00K | 6.00K | -5.00K | 36.00K | 26.00K |
| Net Income | -27.11M | 4.25M | -889.00K | -962.00K | -1.24M |
| EBIT | -875.00K | -1.13M | -626.00K | -771.00K | -1.14M |
| EBITDA | -873.00K | -1.13M | -625.00K | -769.00K | -1.14M |
| EPS Basic | -2.36 | 0.37 | -0.09 | -0.10 | -0.04 |
| Normalized Basic EPS | -0.09 | 0.23 | -0.06 | -0.06 | -0.03 |
| EPS Diluted | -2.36 | 0.06 | -0.09 | -0.10 | -0.05 |
| Normalized Diluted EPS | -0.09 | 0.04 | -0.06 | -0.06 | -0.03 |
| Average Basic Shares Outstanding | 11.51M | 11.50M | 10.00M | 10.00M | 29.50M |
| Average Diluted Shares Outstanding | 11.51M | 72.00M | 10.00M | 10.00M | 29.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |